Energetics of mutation-induced changes in potency of lersivirine against HIV-1 reverse transcriptase.
about
Anti-Hemagglutinin Antibody Derived Lead Peptides for Inhibitors of Influenza Virus BindingLersivirine - a new drug for HIV infection therapy.Novel theoretically designed HIV-1 non-nucleoside reverse transcriptase inhibitors derived from nevirapine.Effects of the protonation state in the interaction of an HIV-1 reverse transcriptase (RT) amino acid, Lys101, and a non nucleoside RT inhibitor, GW420867X.
P2860
Energetics of mutation-induced changes in potency of lersivirine against HIV-1 reverse transcriptase.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Energetics of mutation-induced ...... t HIV-1 reverse transcriptase.
@en
Energetics of mutation-induced ...... t HIV-1 reverse transcriptase.
@nl
type
label
Energetics of mutation-induced ...... t HIV-1 reverse transcriptase.
@en
Energetics of mutation-induced ...... t HIV-1 reverse transcriptase.
@nl
prefLabel
Energetics of mutation-induced ...... t HIV-1 reverse transcriptase.
@en
Energetics of mutation-induced ...... t HIV-1 reverse transcriptase.
@nl
P356
P1476
Energetics of mutation-induced ...... st HIV-1 reverse transcriptase
@en
P2093
Volker Knecht
P304
P356
10.1021/JP300818C
P407
P50
P577
2012-05-22T00:00:00Z